Shanghai Haoyuan Chemexpress Co (SHSE:688131) 3-Year EBITDA Growth Rate : 8.10% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co 3-Year EBITDA Growth Rate?

Shanghai Haoyuan Chemexpress Co's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.40.

During the past 12 months, Shanghai Haoyuan Chemexpress Co's average EBITDA Per Share Growth Rate was 2.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 8.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shanghai Haoyuan Chemexpress Co was 115.90% per year. The lowest was -6.10% per year. And the median was 19.25% per year.

Competitive Comparison of Shanghai Haoyuan Chemexpress Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Haoyuan Chemexpress Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's 3-Year EBITDA Growth Rate falls into.

Shanghai Haoyuan Chemexpress Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Shanghai Haoyuan Chemexpress Co (SHSE:688131) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Shanghai Haoyuan Chemexpress Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Haoyuan Chemexpress Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Haoyuan Chemexpress Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

http://www.chemexpress.com.cn

Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.

Executives

Mei Kui

Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines